Trajan Wealth LLC Sells 1,331 Shares of MetLife, Inc. (NYSE:MET)

Trajan Wealth LLC lowered its stake in shares of MetLife, Inc. (NYSE:MET) by 2.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,832 shares of the financial services provider’s stock after selling 1,331 shares during the quarter. Trajan Wealth LLC’s holdings in MetLife were worth $5,472,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Retirement Wealth Solutions LLC acquired a new position in MetLife in the fourth quarter valued at about $32,000. Sierra Ocean LLC acquired a new position in shares of MetLife in the 4th quarter valued at approximately $32,000. Graney & King LLC acquired a new position in shares of MetLife in the 4th quarter valued at approximately $34,000. Values First Advisors Inc. acquired a new stake in shares of MetLife during the 4th quarter worth approximately $36,000. Finally, Golden State Wealth Management LLC bought a new position in MetLife in the fourth quarter valued at approximately $44,000. Institutional investors own 94.99% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Morgan Stanley reduced their target price on MetLife from $109.00 to $94.00 and set an “overweight” rating on the stock in a report on Thursday, April 10th. Wells Fargo & Company decreased their target price on MetLife from $97.00 to $91.00 and set an “overweight” rating on the stock in a research report on Thursday, April 10th. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Cowen reaffirmed a “buy” rating on shares of MetLife in a report on Friday, March 7th. Finally, UBS Group increased their price objective on shares of MetLife from $94.00 to $98.00 and gave the company a “buy” rating in a research note on Wednesday, April 2nd. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $92.46.

MetLife Stock Performance

Shares of MetLife stock opened at $72.49 on Friday. The stock has a market cap of $49.38 billion, a price-to-earnings ratio of 12.14, a P/E/G ratio of 0.65 and a beta of 0.89. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $89.05. The company’s fifty day moving average is $79.19 and its 200 day moving average is $82.13. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54.

MetLife (NYSE:MET) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Sell-side analysts forecast that MetLife, Inc. will post 9.65 EPS for the current year.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.